Summary

Top ## selected# in Chembl# in DrugBank# in Kegg# in any DB
100 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
200 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
500 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
1005 (5%)0 (0%)0 (0%)0 (0%)0 (0%)
20014 (7%)0 (0%)0 (0%)0 (0%)0 (0%)
50068 (14%)0 (0%)0 (0%)0 (0%)0 (0%)
1000247 (25%)3 (1%)7 (3%)4 (2%)11 (4%)

Ranking of Drug—Target Pairs

Rank CH DB KG Drug Target Most Similar Drug Most Similar Target
70NNNMoricizine hydrochloride
KCNK5: potassium channel, subfamily K, member 50.43243Dyclonine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
74NNNAmiloride hydrochloride
SCN4B0.26923Riluzole
0.025789ACCN1: amiloride-sensitive cation channel 1, neuronal
83NNNAmiloride hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.26923Riluzole
0.087772CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
92NNNAmiloride hydrochloride
SCN1B: sodium channel, voltage-gated, type I, beta0.26923Riluzole
0.024163ACCN3: amiloride-sensitive cation channel 3
95NNNAmiloride hydrochloride
SCN3B: sodium channel, voltage-gated, type III, beta0.26923Riluzole
0.024794ACCN1: amiloride-sensitive cation channel 1, neuronal
110NNNPhenytoin
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.37500Dizocilpine maleate
0.022827SCN4B
111NNNVerapamil
GRIA3: glutamate receptor, ionotrophic, AMPA 30.20000Riluzole
0.026689KCNE1: potassium voltage-gated channel, Isk-related family, member 1
114NNNVerapamil
GRIA4: glutamate receptor, ionotrophic, AMPA 40.20000Riluzole
0.026577KCNE1: potassium voltage-gated channel, Isk-related family, member 1
117NNNFlecainide acetate
KCNK5: potassium channel, subfamily K, member 50.38461Dyclonine hydrochloride
0.030801KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
150NNNLamotrigine
KCNK5: potassium channel, subfamily K, member 50.30435Diazoxide
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
164NNNDiazoxide
GRID2: glutamate receptor, ionotropic, delta 20.38095Riluzole
0.19653GRIA2: glutamate receptor, ionotropic, AMPA 2
176NNNDoxorubicin hydrochloride
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.23729Glyburide
0.0043818RYR2: ryanodine receptor 2 (cardiac)
189NNNKainic acid hydrate
GRID2: glutamate receptor, ionotropic, delta 20Riluzole
0.20292GRIK2: glutamate receptor, ionotropic, kainate 2
194NNNVerapamil
GRIA2: glutamate receptor, ionotropic, AMPA 20.20000Riluzole
0.027448KCNE1: potassium voltage-gated channel, Isk-related family, member 1
206NNNDoxorubicin hydrochloride
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.24624Ketoconazole
0.0071212RYR2: ryanodine receptor 2 (cardiac)
208NNNStreptomycin sulfate
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.066667Glyburide
0.0043818RYR2: ryanodine receptor 2 (cardiac)
210NNNVerapamil
MCOLN1: mucolipin 10.085106Amiloride hydrochloride
0.032255KCNE2: potassium voltage-gated channel, Isk-related family, member 2
217NNNHaloperidol
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.42492Thioridazine hydrochloride
0.015023GRIN2C: glutamate receptor, ionotropic, N-methyl D-aspartate 2C
219NNNHalothane
RYR2: ryanodine receptor 2 (cardiac)0.078947Pimozide
0.021708ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
222NNNVerapamil
TRPC6: transient receptor potential cation channel, subfamily C, member 60.085106Amiloride hydrochloride
0.027859KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
224NNNHalothane
RYR30.078947Pimozide
0.021825ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
228NNNRiluzole
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.45833Hydroflumethiazide
0.016547SCN1B: sodium channel, voltage-gated, type I, beta
229NNNEthosuximide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.47059Butabarbital
0.011438CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
256NNNVerapamil
CLCN2: chloride channel 20.11111Lubiprostone
0.022598KCNE2: potassium voltage-gated channel, Isk-related family, member 2
262NNNVerapamil
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.29412Glyburide
0.15287ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
281NNNStreptomycin sulfate
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.075630Verapamil
0.0071212RYR2: ryanodine receptor 2 (cardiac)
288NNNPropofol
GRIA1: glutamate receptor, ionotropic, AMPA 10.22727Diazoxide
0.018959GLRA1: glycine receptor, alpha 1
301NNNHalothane
RYR1: ryanodine receptor 1 (skeletal)0.078947Pimozide
0.021654ITPR1: inositol 1,4,5-trisphosphate receptor, type 1
310NNNKetamine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.38710Thioridazine hydrochloride
0.024001GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
329NNNPropofol
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.26471Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
336NNNMagnesium sulfate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.027027Nifedipine
0.19447CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
343NNNParamethadione
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.30435Methohexital
0.011438CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
354NNNVerapamil
CHRND: cholinergic receptor, nicotinic, delta0.29268Metoclopramide
0.029958KCNE3: potassium voltage-gated channel, Isk-related family, member 3
360NNNVerapamil
GRID2: glutamate receptor, ionotropic, delta 20.20000Riluzole
0.020345KCNE1L: KCNE1-like
363NNNDofetilide
KCNK6: potassium channel, subfamily K, member 60.41270Ibutilide fumarate
0.19314KCNK2: potassium channel, subfamily K, member 2
369NNNVerapamil
P2RX2: purinergic receptor P2X, ligand-gated ion channel, 20.17500Caffeine
0.042682KCNK4: potassium channel, subfamily K, member 4
370NNNDiazoxide
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.27027Glyburide
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
371NNNFlecainide acetate
GRIA1: glutamate receptor, ionotropic, AMPA 10.27027Riluzole
0.015652KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
374NNNVerapamil
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.29268Metoclopramide
0.035142KCNK4: potassium channel, subfamily K, member 4
375NNNIndapamide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.42857Benzthiazide
0.022575KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
376NNNAmlexanox
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.38235Caffeine and sodium benzoate
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
381NNNTolbutamide
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.41667Glyburide
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
386NNNLevetiracetam
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.26087Ketamine hydrochloride
0.0099594SCN1A: sodium channel, voltage-gated, type I, alpha subunit
391NNNDiazoxide
CLCN2: chloride channel 20.051282Lubiprostone
0.022598KCNE2: potassium voltage-gated channel, Isk-related family, member 2
392NNNVerapamil
SLC6A14: solute carrier family 6 (amino acid transporter), member 140Proline
0.033290KCNK17: potassium channel, subfamily K, member 17
394NNNIbutilide fumarate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.29167Verapamil
0.19447CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
397NNNEthosuximide
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.15790Gabapentin
0.12631CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
399NNNAmlexanox
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.37500Repaglinide
0.013742ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
401NNNVerapamil
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70Proline
0.031499KCNK16: potassium channel, subfamily K, member 16
410NNNEncainide hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.47059Bupivacaine hydrochloride
0.016875SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
417NNNVerapamil
GLRA30.14583Tropisetron hydrochloride
0.029733KCNE1L: KCNE1-like
421NNNPenfluridol
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.48936Astemizole
0.013728CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
432NNNLubiprostone
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.25926Penicillin G procaine
0.013899CLCN2: chloride channel 2
433NNNVerapamil
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.12245Cocaine
0.033720CACNG1: calcium channel, voltage-dependent, gamma subunit 1
440NNNDiazoxide
MCOLN1: mucolipin 10.18518Amiloride hydrochloride
0.032255KCNE2: potassium voltage-gated channel, Isk-related family, member 2
445NNNDiazoxide
TRPC6: transient receptor potential cation channel, subfamily C, member 60.18518Amiloride hydrochloride
0.027859KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
456NNNDopamine hydrochloride
GLRA30.21429Tropisetron hydrochloride
0.095753HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
462NNNVerapamil
P2RX7: purinergic receptor P2X, ligand-gated ion channel, 70.17500Caffeine
0.027427KCNE2: potassium voltage-gated channel, Isk-related family, member 2
466NNNOndansetron hydrochloride hydrate
GLRA30.34286Tropisetron hydrochloride
0.095753HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
468NNNTrifluoperazine maleate
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.45833Thioridazine hydrochloride
0.030674KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
470NNNBenzocaine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.31034Nitrendipine
0.12677SCN3A: sodium channel, voltage-gated, type III, alpha subunit
474NNNBenzocaine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.31034Nitrendipine
0.12915SCN3A: sodium channel, voltage-gated, type III, alpha subunit
479NNNTrimethadione
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.28571Hexobarbital
0.0087226CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
486NNNDantrolene
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.41935Clobazam
0.0064074RYR1: ryanodine receptor 1 (skeletal)
487NNNCetiedil citrate
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.20690Glyburide
0.010929KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
490NNNDisopyramide
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.34884Verapamil
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
492NNNKetoconazole
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.40816Glyburide
0.011075KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
495NNNDiazoxide
SCN4B0.40000Zonisamide
0.044678KCNE1: potassium voltage-gated channel, Isk-related family, member 1
501NNNCetiedil citrate
CHRNA20.33962Nicotine bitartrate
0.019239KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
503NNNRiluzole
GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 10.23077Ketamine hydrochloride
0.15710GRIK1: glutamate receptor, ionotropic, kainate 1
506NNNVerapamil
P2RX5: purinergic receptor P2X, ligand-gated ion channel, 50.17500Caffeine
0.045889KCNE1L: KCNE1-like
516NNNDisopyramide
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.34884Verapamil
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
517NNNMefloquine hydrochloride
GRIA1: glutamate receptor, ionotropic, AMPA 10.31250Riluzole
0.011082KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
518NNNGlyburide
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.40816Ketoconazole
0.017942ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
520NNNDiazepam
GRIA1: glutamate receptor, ionotropic, AMPA 10.30769Diazoxide
0.018959GLRA1: glycine receptor, alpha 1
524YYYRepaglinide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.43478Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
525NNNIbutilide fumarate
KCNK16: potassium channel, subfamily K, member 160.29167Verapamil
0.24996KCNK6: potassium channel, subfamily K, member 6
527NNNZonisamide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.40000Diazoxide
0.016547SCN1B: sodium channel, voltage-gated, type I, beta
528NNNVerapamil
P2RX3: purinergic receptor P2X, ligand-gated ion channel, 30.17500Caffeine
0.030341KCNE2: potassium voltage-gated channel, Isk-related family, member 2
533NNNAmlodipine maleate
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.48837Nisoldipine
0.018083CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
535NNNHalazepam
GRIA1: glutamate receptor, ionotropic, AMPA 10.39286Riluzole
0.011445GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
537NNNAmlodipine besylate
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.48837Nitrendipine
0.018083CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
539NNNVerapamil
P2RX6: purinergic receptor P2X, ligand-gated ion channel, 60.17500Caffeine
0.029220KCNE3: potassium voltage-gated channel, Isk-related family, member 3
544NNNDiazoxide
CHRND: cholinergic receptor, nicotinic, delta0.25926Metoclopramide
0.029958KCNE3: potassium voltage-gated channel, Isk-related family, member 3
546NNNDequalinium chloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.34783Thioridazine hydrochloride
0.032967KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
547NNNVerapamil
GABRR20.30233Zaleplon
0.030883KCNE1L: KCNE1-like
555NNNMefloquine hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.47500Flecainide acetate
0.081115KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
560NNNPramoxine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.38461Flecainide acetate
0.026637KCNK5: potassium channel, subfamily K, member 5
561NYYNateglinide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.36585Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
563NNNVerapamil
P2RX1: purinergic receptor P2X, ligand-gated ion channel, 10.17500Caffeine
0.045455KCNE3: potassium voltage-gated channel, Isk-related family, member 3
564NNNExemestane
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.34483Hexobarbital
0.090264CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
565NNNRiluzole
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38095Diazoxide
0.025836SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
570NYNMagnesium sulfate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.027027Nifedipine
0.015801CACNG1: calcium channel, voltage-dependent, gamma subunit 1
577NNNCyproheptadine hydrochloride
CHRNA20.39317Tubocurarine chloride
0.018097KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
581NNNZonisamide
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.22222Phenytoin
0.12631CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
582NNNDofetilide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.41026Benzthiazide
0.022874KCNK2: potassium channel, subfamily K, member 2
583NNNIbutilide fumarate
KCNK2: potassium channel, subfamily K, member 20.41270Dofetilide
0.20401KCNK1: potassium channel, subfamily K, member 1
590NNNDiazoxide
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.25926Metoclopramide
0.035142KCNK4: potassium channel, subfamily K, member 4
596NNNMagnesium sulfate
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.10345Glyclopyramide
0.025831CACNG1: calcium channel, voltage-dependent, gamma subunit 1
600NNNLetrozole
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.34884Ketoconazole
0.017956CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
604NNNGranisetron
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.48387Nateglinide
0.017658HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
606NNNDiazoxide
SCN3B: sodium channel, voltage-gated, type III, beta0.40000Zonisamide
0.046014KCNE2: potassium voltage-gated channel, Isk-related family, member 2
610NNNDequalinium chloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.40000Halofantrine hydrochloride
0.017196KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
620NNNDiazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38889Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
626NNNDiazoxide
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.16129Cocaine
0.026833KCND2: potassium voltage-gated channel, Shal-related subfamily, member 2
633NNNBenzocaine
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.31034Nitrendipine
0.13951SCN3A: sodium channel, voltage-gated, type III, alpha subunit
637NNNVerapamil
P2RX4: purinergic receptor P2X, ligand-gated ion channel, 40.17500Caffeine
0.033352KCNE2: potassium voltage-gated channel, Isk-related family, member 2
641NNNDiazoxide
SCN1B: sodium channel, voltage-gated, type I, beta0.40000Zonisamide
0.045507KCNE2: potassium voltage-gated channel, Isk-related family, member 2
647NNNHalofantrine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.012494KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
649NNNPhentermine
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.38889Mexiletine hydrochloride
0.010278SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
650NNNDyclonine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.45161Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
651NNNDiazoxide
P2RX2: purinergic receptor P2X, ligand-gated ion channel, 20.21739Caffeine
0.042682KCNK4: potassium channel, subfamily K, member 4
656NNNNateglinide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.44828Mepivacaine hydrochloride
0.0099976KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
664NNNRiluzole
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.26923Amiloride hydrochloride
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
667NNNBepridil hydrochloride
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.45714Trimipramine
0.014048KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
669NNNDisopyramide
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.34884Verapamil
0.13951SCN3A: sodium channel, voltage-gated, type III, alpha subunit
682NNNAmlexanox
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38710Furosemide
0.010906ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
683NNNBenzocaine
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.45000Felbamate
0.022827SCN4B
685NNNPhenacemide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.38461Nateglinide
0.011295SCN1A: sodium channel, voltage-gated, type I, alpha subunit
691NNNMefloquine hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.31707Bendroflumethiazide
0.022575KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
695NNNDiazoxide
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.40000Zonisamide
0.030864KCNV1: potassium channel, subfamily V, member 1
698NYNMagnesium sulfate
CACNB1: calcium channel, voltage-dependent, beta 1 subunit0.042857Ibutilide fumarate
0.016265CACNG1: calcium channel, voltage-dependent, gamma subunit 1
703NNNCodeine sulfate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.39744Quinine sulfate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
704NNNVerapamil
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.36585Profenamine hydrochloride
0.023718KCNE2: potassium voltage-gated channel, Isk-related family, member 2
708NNNMefloquine hydrochloride
GLRA1: glycine receptor, alpha 10.32432Tropisetron hydrochloride
0.015107KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
709NNNFelbamate
GRIA1: glutamate receptor, ionotropic, AMPA 10.18518Riluzole
0.092521GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
713NNNAzimilide dihydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.015344KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
716NNNEthchlorvynol
GRIA1: glutamate receptor, ionotropic, AMPA 10.21429Methoxyflurane
0.011445GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
722NNNVerapamil
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.23404Ondansetron hydrochloride hydrate
0.042488KCNMB1: potassium large conductance calcium-activated channel, subfamily M, beta member 1
726NYNAmlodipine besylate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.48837Nitrendipine
0.017211CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
733NNNDiazoxide
SLC6A14: solute carrier family 6 (amino acid transporter), member 140Proline
0.033290KCNK17: potassium channel, subfamily K, member 17
738NNNFluphenazine maleate
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.48837Thioridazine hydrochloride
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
740NNNEthosuximide
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.44444Pentobarbital
0.0094499CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
745NNNDopamine hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.35294Chlorzoxazone
0.015696HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
748NNNMefloquine hydrochloride
KCNE1: potassium voltage-gated channel, Isk-related family, member 10.24390Indapamide
0.026945KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
751NNNDiazoxide
GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 10.29167Ketamine hydrochloride
0.14656GRIA1: glutamate receptor, ionotropic, AMPA 1
752NNNMaprotiline
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.45714Moricizine
0.0094747SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
753NNNNicotine bitartrate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.24490Quinine hydrochloride hydrate
0.18777KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
758NNNSumatriptan
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.36000Diazoxide
0.015696HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
761NNNDofetilide
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.41270Ibutilide fumarate
0.011007KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5
764NYNQuinidine sulfate
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.32836Astemizole
0.22326KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1
765NYNAmlodipine maleate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.48837Nisoldipine
0.017211CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
768NNNMibefradil dihydrochloride
PKD1: polycystic kidney disease 1 (autosomal dominant)0.44898Verapamil
0.0049566CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
770NNNDiazoxide
P2RX7: purinergic receptor P2X, ligand-gated ion channel, 70.21739Caffeine
0.027427KCNE2: potassium voltage-gated channel, Isk-related family, member 2
772NNNNortriptyline hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.48387Dizocilpine maleate
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
775NNNMibefradil dihydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.44898Verapamil
0.13474CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
776NNNDiazoxide
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70Proline
0.031499KCNK16: potassium channel, subfamily K, member 16
777NNNPropafenone hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.34091Verapamil
0.21997KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
778NNNAmlodipine besylate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.48837Nitrendipine
0.0092209CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
779NNNDiazoxide
GLRA30.24138Tropisetron hydrochloride
0.029733KCNE1L: KCNE1-like
780NNNPhencyclidine hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.31250Bupivacaine hydrochloride
0.18777KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
781NNNDopamine hydrochloride
GLRA2: glycine receptor, alpha 20.26087Felbamate
0.10113HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
788NNNLamotrigine
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.35000Chlorzoxazone
0.011633SCN3A: sodium channel, voltage-gated, type III, alpha subunit
790NNNDiazoxide
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.16129Cocaine
0.027170KCNF1: potassium voltage-gated channel, subfamily F, member 1
791NNNPenfluridol
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.48333Trifluoperazine hydrochloride
0.011237CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
794NNNParoxetine
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.43590Cisapride
0.013109SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
798NNNZaleplon
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.37143Disopyramide
0.013396GABRE
802NNNPhysostigmine sulfate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36986Quinine sulfate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
807NNNDiazoxide
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.38095Riluzole
0.092521GRIA1: glutamate receptor, ionotropic, AMPA 1
808NNNDiazoxide
ACCN2: amiloride-sensitive cation channel 2, neuronal0.18518Amiloride hydrochloride
0.026659KCNE1L: KCNE1-like
815NNNDiazoxide
ACCN1: amiloride-sensitive cation channel 1, neuronal0.18518Amiloride hydrochloride
0.027845KCNE4: potassium voltage-gated channel, Isk-related family, member 4
816NNYBepridil hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.45454Terfenadine
0.017204KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
817NNNDibucaine
KCNK5: potassium channel, subfamily K, member 50.44828Lidocaine
0.011241SCN10A: sodium channel, voltage-gated, type X, alpha subunit
820NNNSertraline
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.48276Midazolam
0.014964SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
822NNNMefloquine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.30769Halazepam
0.015344KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
826NNNCodeine
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.35294Bupivacaine hydrochloride
0.020018CHRNA10
827NNNDiltiazem hydrochloride
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36956Verapamil
0.22001KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
830NNNPenicillin G procaine
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.47676Diltiazem malate
0.011266GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 5
834NNNDiazoxide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.40000Zonisamide
0.025826KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
838NNNIbutilide fumarate
KCNK10: potassium channel, subfamily K, member 100.29167Verapamil
0.18687KCNK1: potassium channel, subfamily K, member 1
839NNNZonisamide
PKD1: polycystic kidney disease 1 (autosomal dominant)0.22222Phenytoin
0.012238SCN1B: sodium channel, voltage-gated, type I, beta
842NNNDizocilpine maleate
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.48387Nortriptyline hydrochloride
0.024221KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
843NNNAmiodarone hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.42105Fluoxetine
0.021769KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
848NNNPromethazine teoclate
RYR1: ryanodine receptor 1 (skeletal)0.40476Caffeine and sodium benzoate
0.0072515KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
849YNNDiazoxide
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.40000Zonisamide
0.025645KCNF1: potassium voltage-gated channel, subfamily F, member 1
850NNNDyclonine hydrochloride
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.43333Tolazamide
0.021462KCNK5: potassium channel, subfamily K, member 5
851NNNKainic acid hydrate
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.28125Dizocilpine maleate
0.096106GRIK2: glutamate receptor, ionotropic, kainate 2
853NNNDizocilpine maleate
GRIK2: glutamate receptor, ionotropic, kainate 20.28125Kainic acid hydrate
0.15526GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 1
854NNNFlurazepam
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.43750Chloroprocaine hydrochloride
0.012903GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2
855NNNSumatriptan
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.40741Tolbutamide
0.021953HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
856NNNAmlodipine maleate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.48837Nisoldipine
0.0092209CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
858NNYFlecainide acetate
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.34146Bupivacaine hydrochloride
0.24349KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
860NNNDiltiazem hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.44444Fluoxetine
0.022791KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
861NNNCarbamazepine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.37037Phenytoin
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
862NNNDiazoxide
P2RX5: purinergic receptor P2X, ligand-gated ion channel, 50.21739Caffeine
0.045889KCNE1L: KCNE1-like
865NNNKainic acid hydrate
SLC6A14: solute carrier family 6 (amino acid transporter), member 140.33333Proline
0.015453GRIK4: glutamate receptor, ionotropic, kainate 4
867NNNSertraline
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.42308Ketamine hydrochloride
0.010907SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
871NNNIndapamide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.41026Glipizide
0.027394KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
872NNNFlecainide acetate
GLRA1: glycine receptor, alpha 10.25714Sevoflurane
0.019946KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
875NNNGlyclopyramide
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.37838Cisapride
0.014705KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
877NNNMibefradil dihydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.44898Verapamil
0.13545CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
878NNNPromethazine teoclate
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.016138KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
881NNNHydroflumethiazide
GRIA1: glutamate receptor, ionotropic, AMPA 10.45833Riluzole
0.0091408KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
883NNNHalazepam
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.48387Fluoxetine
0.016138GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
885NNNNifedipine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.38235Cocaine
0.13474CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
886NNNCaffeine
CLCN2: chloride channel 20.051282Lubiprostone
0.013935P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
887NNNTrichlormethiazide
GRIA1: glutamate receptor, ionotropic, AMPA 10.40000Riluzole
0.0091408KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
889NNNTrifluoperazine hydrochloride
GRIA1: glutamate receptor, ionotropic, AMPA 10.32353Riluzole
0.018721KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
893NNNAmiloride hydrochloride
GRID2: glutamate receptor, ionotropic, delta 20.26923Riluzole
0.014175MCOLN1: mucolipin 1
896NNNFelbamate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.45000Benzocaine
0.010173GLRA2: glycine receptor, alpha 2
898NNNCaffeine
MCOLN1: mucolipin 10.14286Amiloride hydrochloride
0.023510P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
900NNNKainic acid hydrate
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70.33333Proline
0.012768GRIK4: glutamate receptor, ionotropic, kainate 4
903NNNCaffeine
TRPC6: transient receptor potential cation channel, subfamily C, member 60.14286Amiloride hydrochloride
0.016201P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5
904NNNDiazoxide
P2RX3: purinergic receptor P2X, ligand-gated ion channel, 30.21739Caffeine
0.030341KCNE2: potassium voltage-gated channel, Isk-related family, member 2
909NNNAminoglutethimide
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.42105Ethosuximide
0.0080876CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
910NNNDiazoxide
P2RX6: purinergic receptor P2X, ligand-gated ion channel, 60.21739Caffeine
0.029220KCNE3: potassium voltage-gated channel, Isk-related family, member 3
912NNNHalazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38461Diltiazem hydrochloride
0.019068GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
914NNNTrichlormethiazide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.36667Furosemide
0.011447KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
915NNNRiluzole
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.26923Amiloride hydrochloride
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
917NNNAzimilide dihydrochloride
KCNE1: potassium voltage-gated channel, Isk-related family, member 10.21818Verapamil
0.026945KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
918NNNFlurazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.46154Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
920NNNFluoxetine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.46875Halazepam
0.021675KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
921NNNEnoxacin hydrate
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.30682Trifluoperazine maleate
0.021832GABRA3: gamma-aminobutyric acid (GABA) A receptor, alpha 3
927NNNDiazoxide
P2RX1: purinergic receptor P2X, ligand-gated ion channel, 10.21739Caffeine
0.045455KCNE3: potassium voltage-gated channel, Isk-related family, member 3
928NNNAmiodarone hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.42105Fluoxetine
0.027535KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
929NNNVerapamil
GRIN2D: glutamate receptor, ionotropic, N-methyl D-aspartate 2D0.28261Haloperidol
0.029109KCNK4: potassium channel, subfamily K, member 4
932NNNIbutilide fumarate
KCNK5: potassium channel, subfamily K, member 50.29167Verapamil
0.17161KCNK1: potassium channel, subfamily K, member 1
935NNNBepridil hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.47059Desipramine hydrochloride
0.035737KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
936NNNDoxorubicin hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.30508Quinidine gluconate
0.0051579RYR1: ryanodine receptor 1 (skeletal)
937NNNDiazoxide
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.29167Ketamine hydrochloride
0.094588GRIA2: glutamate receptor, ionotropic, AMPA 2
938NNNPhencyclidine hydrochloride
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.44444Dextromethorphan
0.015803CHRNA10
939NNNPropafenone hydrochloride
KCNK16: potassium channel, subfamily K, member 160.34091Verapamil
0.24672KCNK5: potassium channel, subfamily K, member 5
940NNNIndapamide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.43333Glyclopyramide
0.029070KCNE1: potassium voltage-gated channel, Isk-related family, member 1
945NNNCodeine
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.38889Quinine hydrochloride hydrate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
946NNNPenicillin G procaine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.40476Procaine hydrochloride
0.011567GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
947NNNPramoxine hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.42105Cisapride
0.019783KCNK5: potassium channel, subfamily K, member 5
953NNNCetiedil citrate
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.31707Methylphenidate
0.022059KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
954NNNQuinine sulfate
CHRNA20.39744Codeine sulfate
0.017256KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
955YNNGlyburide
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.45652Astemizole
0.015300KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
956NNNDofetilide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.41270Ibutilide fumarate
0.025318KCNK2: potassium channel, subfamily K, member 2
958NNNBupivacaine hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.34146Flecainide acetate
0.22153KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
963NNNHalazepam
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.41667Bendroflumethiazide
0.011447GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
964NNNAmiloride hydrochloride
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.36000Lamotrigine
0.12915CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
965NNNTolbutamide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.45833Lidocaine
0.010834KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
967NNNDibucaine
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.40476Halofantrine hydrochloride
0.0091581SCN5A: sodium channel, voltage-gated, type V, alpha subunit
971NNNGalantamine hydrobromide
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36111Quinine hydrochloride hydrate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
973NNNGlyclopyramide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.32000Diazoxide
0.0097843KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
976NNNVerapamil
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.28261Haloperidol
0.026014KCNE1: potassium voltage-gated channel, Isk-related family, member 1
977NNNZonisamide
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.29167Felbamate
0.022827SCN4B
978NNNCarbamazepine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.37037Phenytoin
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
981NNNCaffeine
KCNK12: potassium channel, subfamily K, member 120Halothane
0.019268P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6
986NNNGallopamil hydrochloride
CHRNA20.36508Metocurine iodide
0.010362CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
988NNNNateglinide
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.48387Granisetron
0.017658KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
990NNNAmiloride hydrochloride
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.36000Lamotrigine
0.11479CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
992NNNBiperiden
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.36364Cocaine
0.020712CHRNA2
996NNNKainic acid hydrate
CLCN2: chloride channel 20.22857Lubiprostone
0.012355GRIK4: glutamate receptor, ionotropic, kainate 4
997NNNPrilocaine
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.47826Tolbutamide
0.0099976SCN5A: sodium channel, voltage-gated, type V, alpha subunit